Y-mAbs Therapeutics (YMAB) News Today → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free YMAB Stock Alerts $14.71 -0.13 (-0.88%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineY-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024globenewswire.com - April 26 at 7:05 AMY-mAbs to Present at 2024 ASCO Annual Meetingglobenewswire.com - April 25 at 4:05 PMY-mAbs Therapeutics (NASDAQ:YMAB) Shares Up 7%marketbeat.com - April 23 at 4:47 PMY-mAbs Therapeutics (NASDAQ:YMAB) rises 9.6% this week, taking one-year gains to 161%finance.yahoo.com - April 18 at 1:21 PMY-mAbs Therapeutics (NASDAQ:YMAB) Trading Up 4%marketbeat.com - April 11 at 11:58 AMY-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Given Average Recommendation of "Hold" by Analystsmarketbeat.com - April 10 at 2:30 AMY-mAbs Therapeutics (NASDAQ:YMAB) Shares Down 3.3% marketbeat.com - April 9 at 11:46 AMY-mAbs Therapeutics (NASDAQ:YMAB) Trading Down 3.2%marketbeat.com - April 3 at 3:27 PMY-mAbs Therapeutics (NASDAQ:YMAB) Shares Gap Down to $16.19marketbeat.com - April 2 at 11:19 AMY-mAbs Therapeutics (NASDAQ:YMAB) Stock Price Up 5.9%marketbeat.com - April 1 at 2:01 PMDenali Advisors LLC Sells 69,500 Shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB)marketbeat.com - April 1 at 6:12 AMY-mAbs Therapeutics (NASDAQ:YMAB) Trading Up 3.9%marketbeat.com - March 26 at 12:38 PMY-mAbs Therapeutics (NASDAQ:YMAB) Stock Price Up 4.3%marketbeat.com - March 19 at 11:57 AMY-mAbs Therapeutics Finance Chief Bo Kruse Resignsmarketwatch.com - March 15 at 8:31 AMY-mAbs Therapeutics, Inc.: Y-mAbs Therapeutics Announces Resignation of Chief Financial Officerfinanznachrichten.de - March 14 at 2:58 PMY-mAbs Therapeutics (NASDAQ:YMAB) Shares Gap Down to $15.84marketbeat.com - March 14 at 11:56 AMY-mAbs Therapeutics CFO Bo Kruse To Retiremarkets.businessinsider.com - March 14 at 9:57 AMY-mAbs Therapeutics Announces Resignation of Chief Financial Officerglobenewswire.com - March 14 at 9:05 AMGSA Capital Partners LLP Acquires 92,765 Shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB)marketbeat.com - March 13 at 5:32 AMY-mAbs Therapeutics (NASDAQ:YMAB) Stock Price Down 8.3%marketbeat.com - March 11 at 11:52 AMY-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Holdings Raised by Trexquant Investment LPmarketbeat.com - March 11 at 5:14 AMCracking The Code: Understanding Analyst Reviews For Y-mAbs Therapeuticsmarkets.businessinsider.com - March 6 at 6:21 PMY-mAbs Therapeutics (NASDAQ:YMAB) Shares Up 8.2% Following Analyst Upgrademarketbeat.com - March 6 at 11:45 AMHC Wainwright Raises Y-mAbs Therapeutics (NASDAQ:YMAB) Price Target to $22.00marketbeat.com - March 6 at 8:25 AMY-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 4 at 1:15 PMY-mAbs Therapeutics (NASDAQ:YMAB) Price Target Raised to $26.00 at Canaccord Genuity Groupmarketbeat.com - March 4 at 10:25 AMY-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of Directorsglobenewswire.com - March 4 at 7:30 AMY-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of Directorsglobenewswire.com - March 4 at 7:30 AMY-mAbs Therapeutics Full Year 2023 Earnings: Beats Expectationsfinance.yahoo.com - March 3 at 2:52 PMQ4 2023 Y-mAbs Therapeutics Inc Earnings Callfinance.yahoo.com - March 2 at 1:35 AMY-mAbs Therapeutics (NASDAQ:YMAB) Sets New 1-Year High at $20.90marketbeat.com - March 1 at 10:37 AMY-mAbs Therapeutics, Inc.: Y-mAbs Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developmentsfinanznachrichten.de - March 1 at 10:34 AMY-mAbs up 17% after hours on strong 2024 guidance, quarterly beatsmsn.com - February 29 at 6:39 PMY-mAbs Therapeutics Inc (YMAB) Reports Strong Revenue Growth in Q4 and Full Year 2023finance.yahoo.com - February 29 at 6:39 PMY-mAbs Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developmentsglobenewswire.com - February 29 at 4:05 PMY-mAbs Therapeutics FY 2023 Earnings Previewmsn.com - February 28 at 6:15 PMHere's what Wall Street expects from Y-mAbs Therapeutics's earningsmarkets.businessinsider.com - February 28 at 1:06 PMY-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Shares Purchased by Acadian Asset Management LLCmarketbeat.com - February 25 at 6:16 AMY-mAbs Therapeutics Inc.wsj.com - February 21 at 6:08 PMY-mAbs Therapeutics (NASDAQ:YMAB) Sets New 12-Month High After Analyst Upgrademarketbeat.com - February 20 at 10:17 AMHC Wainwright Boosts Y-mAbs Therapeutics (NASDAQ:YMAB) Price Target to $21.00marketbeat.com - February 20 at 8:18 AMY-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Receives Consensus Rating of "Hold" from Brokeragesmarketbeat.com - February 20 at 1:37 AMYMAB Mar 2024 20.000 callfinance.yahoo.com - February 17 at 11:49 AMYMAB Mar 2024 10.000 callfinance.yahoo.com - February 17 at 6:49 AMCRISPR Therapeutics AG (CRSP) Moves 6.9% Higher: Will This Strength Last?finance.yahoo.com - February 16 at 12:37 PMY-mAbs to Announce Fourth Quarter and Full Year 2023 Financial and Operating Results on February 29, 2024finance.yahoo.com - February 16 at 7:37 AMY-mAbs to Announce Fourth Quarter and Full Year 2023 Financial and Operating Results on February 29, 2024globenewswire.com - February 16 at 7:30 AMWedbush Research Analysts Increase Earnings Estimates for Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB)marketbeat.com - February 14 at 8:29 AMY-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Shares Acquired by Massachusetts Financial Services Co. MAmarketbeat.com - February 14 at 5:27 AMY-mAbs Therapeutics (NASDAQ:YMAB) Stock Price Up 3.3%marketbeat.com - February 13 at 1:32 PM Get Y-mAbs Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for YMAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. YMAB Media Mentions By Week YMAB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. YMAB News Sentiment▼0.530.32▲Average Medical News Sentiment YMAB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. YMAB Articles This Week▼32▲YMAB Articles Average Week Get Y-mAbs Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for YMAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SLN News Today COGT News Today EOLS News Today BCYC News Today DNTH News Today IRON News Today PHAR News Today NRIX News Today SVRA News Today AVTE News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:YMAB) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Y-mAbs Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
